Jihong Ma, MD
Assistant Research Professor, Surgery-Plastic/Reconstructive
Publications
- CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model. Wang Z, Ma J, Zhang H, Ramakrishna R, Mintzlaff D, Mathes DW, Pomfret EA, Lucia MS, Gao D, Haverkos BM, Wang Z.
Specialty Information
Specialties- Infectious Disease